Lonza: 4D-Nucleofector cell transfection platform
Lonza has expanded its Nucleofector line with the 4D-Nucleofector cell transfection platform. The machine reportedly includes an updated core unit and intuitive software.
“The Nucleofector technology has been used for more than 10,000 peer-reviewed publications since its introduction 20 years ago, clearly demonstrating its importance for this community of successful researchers,” said Nina Novak, product manager for Nucleofection technology for Lonza. “The next-generation 4D-Nucleofector Platform brings UX improvements that make the system even more intuitive and easy to use, firmly securing its place as a core method in cell-based research.”
